Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Christopher M. Duma"'
Autor:
Daniela A. Bota, Thomas H. Taylor, David E. Piccioni, Christopher M. Duma, Renato V. LaRocca, Santosh Kesari, Jose A. Carrillo, Mehrdad Abedi, Robert D. Aiken, Frank P. K. Hsu, Xiao-Tang Kong, Candace Hsieh, Peter G. Bota, Gabriel I. Nistor, Hans S. Keirstead, Robert O. Dillman
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 41, Iss 1, Pp 1-9 (2022)
Abstract Background Vaccine immunotherapy may improve survival in Glioblastoma (GBM). A multicenter phase II trial was designed to determine: (1) the success rate of manufacturing the Aivita GBM vaccine (AV-GBM-1), (2) Adverse Events (AE) associated
Externí odkaz:
https://doaj.org/article/5a31d54aac0647619b0bae78c1eddb03
Autor:
Oleg V. Kopyov Ph.D., M.D., Deane “Skip” Jacques, Abraham Lieberman, Christopher M. Duma, Robert L. Rogers
Publikováno v:
Cell Transplantation, Vol 5 (1996)
This study reports our findings from 22 patients (ages ranging from 42 to 73 yr; mean = 55.2) with recalcitrant idiopathic Parkinson's disease (PD) who received implants of fetal ventral mesencephalic tissue using an MRI-guided stereotactic procedure
Externí odkaz:
https://doaj.org/article/566d75cf4c594fc5809d0ac5448a3f3a
Autor:
Daniela A. Bota, David E. Piccioni, Christopher M. Duma, Renato V. LaRoca, Santosh Kesari, Mehrdad Abedi, Robert D. Aiken, Aleksandra J. Poole, Gabriel I. Nistor, Robert O. Dillman
Publikováno v:
Cancer Research. 82:CT571-CT571
Standard aggressive therapy for primary newly diagnosed glioblastoma (GBM), which includes surgical resection followed by concurrent radiation therapy and temozolomide chemotherapy (RT/TMZ) and then maintenance TMZ, is associated with poor survival r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::707661ae9efe26d6250863b7c037b8f1
https://doi.org/10.1158/1538-7445.am2022-ct571
https://doi.org/10.1158/1538-7445.am2022-ct571
Autor:
Christopher M. Duma
Publikováno v:
Techniques in Neurosurgery. 9:181-190
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8579985cbab48a76e6b795d7da5c8f56
https://doi.org/10.1097/00127927-200309030-00011
https://doi.org/10.1097/00127927-200309030-00011
Autor:
Christopher M. Duma, Deane 'skip' Jacques, Abraham Lieberman, Robert L. Rogers, Oleg V. Kopyov
Publikováno v:
Experimental Neurology. 146:536-545
The effect of varying the volume of grafted fetal mesencephalic tissue was studied in patients with idiopathic Parkinson's disease in a single-blinded study. Evaluations were performed according to the Core Assessment Program for Intracerebral Transp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27a6ed5925f5349b6636b5ac0990788e
https://doi.org/10.1006/exnr.1997.6577
https://doi.org/10.1006/exnr.1997.6577
Autor:
Deane 'skip' Jacques, Robert L. Rogers, Christopher M. Duma, Abraham Lieberman, Oleg V. Kopyov
Publikováno v:
Cell Transplantation, Vol 5 (1996)
This study reports our findings from 22 patients (ages ranging from 42 to 73 yr; mean = 55.2) with recalcitrant idiopathic Parkinson's disease (PD) who received implants of fetal ventral mesencephalic tissue using an MRI-guided stereotactic procedure
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35f25f5187f7128a024ca7c3f2f2d44a
https://doi.org/10.1016/0963-6897(95)02035-7
https://doi.org/10.1016/0963-6897(95)02035-7
Autor:
Christopher M, Duma
Publikováno v:
Progress in neurological surgery. 20
Gamma Knife radiosurgical thalamotomy is an effective and useful alternative to invasive radiofrequency techniques for patients at high surgical risk. The mechanical accuracy of the gamma unit combined with the anatomical accuracy of high-resolution
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f1b4914bce39cb27dbcb16255f1222fd
https://pubmed.ncbi.nlm.nih.gov/17317994
https://pubmed.ncbi.nlm.nih.gov/17317994
Autor:
Robert O. Dillman, Andreea A. Nanci, Scott T. Williams, Richard B. Kim, Russell L. Hafer, Colleen L. Coleman, Peter C. Wang, Christopher M. Duma, Peter V. Chen, Senthamil R. Selvan, Andrew N. Cornforth, Carol DePriest
Publikováno v:
Cancer Biotherapy & Radiopharmaceuticals; Oct2010, Vol. 25 Issue 5, p553-557, 5p